ARTICLE 19 raises concerns over Spain s Ministerial Order on Disinformation ifex.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ifex.org Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The "Global SERD Therapeutics Market 2019-2030: Focus on Product, Therapy, Country Data (14 Countries), and Competitive Landscape" report has.
Apply for a licence to market a medicine in the UK
How to license a medicine for sale in the UK, including applications through national and international routes.
From: Contents
Print this page
This guidance also covers licensing a medicine in Northern Ireland through the centralised, decentralised and mutual recognition European procedures.
Which procedure to follow
There are several routes to obtain a marketing authorisation in the United Kingdom (UK), Great Britain (England, Scotland and Wales) or Northern Ireland. The options available will be determined by the intended market and the type of application. The markets in which each route is applicable are indicated in the following guidance:
Share this article
Share this article
ResearchAndMarkets.com s offering.
The scientific community has been pursuing research for the development of CAR T-cell therapy for over a century. Immunotherapy has emerged as an innovative treatment option over decades, as it harnesses the patient s immune system to attack cancer. The global market for CAR T-cell therapy is predicted to grow at a CAGR of 44.79% over the forecast period 2020-2030. The market is driven by certain factors, which include increasing global geriatric population, increasing number of lymphoma and leukemia cases, rising number of relapsed or refractory cancer cases showing response failure to alternative treatments such as chemotherapy and radiation therapy, focus on research and development of novel immunotherapies, and strong product pipeline of global CAR T-cell therapy.